The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis.
Ronden MI, Bahce I, Claessens NJM, Barlo N, Dahele MR, Daniels JMA, Tissing-Tan C, Hekma E, Hashemi SMS, van der Wel A, Spoelstra FOB, Verbakel WFAR, Tiemessen MA, van Laren M, Becker A, Tarasevych S, Haasbeek CJA, Maassen van den Brink K, Dickhoff C, Senan S.
Ronden MI, et al. Among authors: daniels jma.
JTO Clin Res Rep. 2021 Jun 6;2(7):100195. doi: 10.1016/j.jtocrr.2021.100195. eCollection 2021 Jul.
JTO Clin Res Rep. 2021.
PMID: 34590040
Free PMC article.